Evidence map›Paper›PMID 7680666›Full record

ArticleThe Journal of clinical investigation1993

Antisense oligodeoxynucleotide to the cystic fibrosis transmembrane conductance regulator inhibits cyclic AMP-activated but not calcium-activated cell volume reduction in a human pancreatic duct cell line.

H Kopelman, C Gauthier, M Bornstein

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Adenosine receptors in rat and human pancreatic ducts stimulate chloride transport.Pflugers Archiv : European journal of physiology · 2008
    Article
  2. Article
  3. Article
  4. Cystic fibrosis gene encodes a cAMP-dependent chloride channel in heart.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  5. Article
  6. An immortal cell line to study the role of endogenous CFTR in electrolyte absorption.In vitro cellular & developmental biology. Animal · 1995
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

H KopelmanDivision of Gastroenterology, Montreal Children's Hospital-McGill University Research Institute, Quebec, Canada.
C Gauthier
M Bornstein
McGill University · CAMontreal Children's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is characterized by a defect in cAMP-regulated chloride channels in epithelial cells. The CF gene product CF transmembrane conductance regulator (CFTR) is expressed in the apical membrane of pancreatic duct cells, and mutant CFTR accounts for the pathology in the CF pancreas. PANC 1, a pancreatic duct cell line, has not been considered a good model for studying CFTR and pancreatic chloride transport because CFTR mRNA and protein are undetectable using standard methods. Using electronic cell sizing and cell volume reduction under isotonic conditions, PANC 1 cells were found to possess both cAMP and calcium-activated chloride conductances. Using CFTR antisense oligodeoxynucleotides, the cAMP-activated conductance could be specifically inhibited in a concentration- and time-dependent manner. These findings demonstrate that PANC 1 cells express CFTR and a CFTR-independent calcium-activated chloride channel. With electronic cell sizing and CFTR antisense oligodeoxynucleotides, PANC 1 cells can provide an ideal system for the study of pancreatic duct cell physiology and pathophysiology with respect to the role of CFTR in the pancreas. These findings also suggest that antisense oligodeoxynucleotides may provide a more sensitive yet highly specific means of detecting low levels of expression of CFTR than currently available.

Indexed as

8-Bromo Cyclic Adenosine MonophosphateBase SequenceCalciumCell LineChloridesColforsinCyclic AMPCystic Fibrosis Transmembrane Conductance RegulatorDose-Response Relationship, DrugHumansIonomycinKineticsMembrane ProteinsMolecular Sequence DataOligonucleotides, AntisensePancreas8-Bromo Cyclic Adenosine MonophosphateCalciumCFTR protein, humanChloridesColforsinCyclic AMPCystic Fibrosis Transmembrane Conductance RegulatorIonomycinMembrane ProteinsOligonucleotides, Antisense

Identifiers

PMID7680666
PMCPMC288086
OpenAlexW2129391213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.